Brigit Biofarmaka Teknologi Tbk. vs Soechi Lines Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 164.65B, 45.1K 24h volume), while Soechi Lines Tbk. trades at Rp498 (market cap 3.47T, 4.9M 24h volume). The key difference: Soechi Lines Tbk. is far larger — about 21.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Soechi Lines Tbk. is more actively traded (4.9M versus 45.1K). Which is the better fit depends on your goals.
| OBAT | SOCI | |
|---|---|---|
Market Cap | 164.65B | 3.47T |
Volume | 45.1K | 4.9M |
Lot | 451 | 49.01K |
Turnover | 10.89M | 2.43B |
Average Price | 241.39 | 496.67 |
Value | 10.89M | 2.43B |
Indicative Equilibrium Price | 238 | 496 |
Indicative Equilibrium Volume | 100 | 154 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Soechi Lines Tbk (the Company) was established in Jakarta based on the Notarial Deed No.16 of Meissie Pholuan, S.H., dated August 13, 2010.
Read more on SOCI →